Business Description
Palisade Bio Inc
NAICS : 325412
SIC : 2834
ISIN : US6963892046
Description
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 22.52 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 78 | |||||
| 3-Year EPS without NRI Growth Rate | 78.8 | |||||
| 3-Year FCF Growth Rate | 72.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 50.67 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 4.82 | |||||
| 9-Day RSI | 11.76 | |||||
| 14-Day RSI | 20.68 | |||||
| 3-1 Month Momentum % | -44.72 | |||||
| 6-1 Month Momentum % | -61.47 | |||||
| 12-1 Month Momentum % | -77.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.31 | |||||
| Quick Ratio | 3.31 | |||||
| Cash Ratio | 3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -334.1 | |||||
| Shareholder Yield % | -160.16 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -5023.2 | |||||
| ROE % | -135.2 | |||||
| ROA % | -106.59 | |||||
| ROIC % | -996.54 | |||||
| 3-Year ROIIC % | 117.64 | |||||
| ROC (Joel Greenblatt) % | -7993.17 | |||||
| ROCE % | -133.17 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.49 | |||||
| PB Ratio | 0.17 | |||||
| Price-to-Tangible-Book | 0.17 | |||||
| EV-to-EBIT | 0.37 | |||||
| EV-to-EBITDA | 0.37 | |||||
| EV-to-Revenue | -21.02 | |||||
| EV-to-Forward-Revenue | 0.76 | |||||
| EV-to-FCF | 0.42 | |||||
| Price-to-Net-Current-Asset-Value | 0.19 | |||||
| Price-to-Net-Cash | 0.22 | |||||
| Earnings Yield (Greenblatt) % | 270.27 | |||||
| FCF Yield % | -517.64 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PALI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Palisade Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.25 | ||
| EPS (TTM) ($) | -13.99 | ||
| Beta | 1.61 | ||
| 3-Year Sharpe Ratio | -1.64 | ||
| 3-Year Sortino Ratio | -1.72 | ||
| Volatility % | 45.04 | ||
| 14-Day RSI | 20.68 | ||
| 14-Day ATR ($) | 0.114186 | ||
| 20-Day SMA ($) | 1.10661 | ||
| 12-1 Month Momentum % | -77.45 | ||
| 52-Week Range ($) | 0.8 - 9.65 | ||
| Shares Outstanding (Mil) | 2.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Palisade Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Palisade Bio Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Palisade Bio Inc Frequently Asked Questions
What is Palisade Bio Inc(PALI)'s stock price today?
The current price of PALI is $0.82. The 52 week high of PALI is $9.65 and 52 week low is $0.80.
When is next earnings date of Palisade Bio Inc(PALI)?
The next earnings date of Palisade Bio Inc(PALI) is .
Does Palisade Bio Inc(PALI) pay dividends? If so, how much?
Palisade Bio Inc(PALI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers